Tech Company Financing Transactions

Laguna Pharmaceuticals Funding Round

Laguna Pharmaceuticals closed a $30 million Series B investment round on 2/17/2015. Backers included Frazier Healthcare Partners, Versant Ventures and BioMed Ventures.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

Undisclosed
La Jolla, CA 92130
USA

Phone

Undisclosed

Website

www.lagunarx.com

Email Address

Not Recorded

Overview

Laguna Pharmaceuticals, formerly known as ChanRx, is a biopharmaceutical company advancing vanoxerine for treatment of atrial fibrillation and atrial flutter.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Bob Baltera

        

Browse more venture capital transactions:

Prev: 2/16/2015: Endotronix venture capital transaction
Next: 2/18/2015: Ticket Evolution venture capital transaction

Share this article

About Database of VC Transactions

We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary